ArticleNature2010
Drug discovery: Priming the antimalarial pipeline.
Article in Nature, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed.
- Highly Regioselective Protecting-Group-Free Synthesis of the Antimalarial Drug MMV693183.Organic process research & development · 2024Article
- Assessing Spectral Analysis of Phytoconstituents and TheirPlants (Basel, Switzerland) · 2023Article
- Dephospho-Coenzyme A Kinase Is an Exploitable Drug Target against Plasmodium falciparum: Identification of Selective Inhibitors by High-Throughput Screening of a Large Chemical Compound Library.Antimicrobial agents and chemotherapy · 2022Article
- Gametocyte-specific and all-blood-stage transmission-blocking chemotypes discovered from high throughput screening on Plasmodium falciparum gametocytes.Communications biology · 2022Article
- The Nitrobenzoxadiazole Derivative NBDHEX Behaves asPharmaceuticals (Basel, Switzerland) · 2022Article
- Nanotechnology approaches for global infectious diseases.Nature nanotechnology · 2021Review
- Characterization ofFrontiers in cellular and infection microbiology · 2021Article
- In vitro anti-malarial efficacy of chalcones: cytotoxicity profile, mechanism of action and their effect on erythrocytes.Malaria journal · 2019Article
- Structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase-dihydropteroate synthase fromThe Journal of biological chemistry · 2018Article
- Biotechnological approaches for artemisinin production in Artemisia.World journal of microbiology & biotechnology · 2018Review
- Modular Three-Component Synthesis of 4-Aminoquinolines via an Imidoylative Sonogashira/Cyclization Cascade.The Journal of organic chemistry · 2018Article
- In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine.Malaria journal · 2017Article
- Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors.Malaria journal · 2017Article
- Bioluminescence Method forAntimicrobial agents and chemotherapy · 2017Article
- Antiplasmodial dihetarylthioethers target the coenzyme A synthesis pathway in Plasmodium falciparum erythrocytic stages.Malaria journal · 2017Article
- Antimalarial efficacy of MMV390048, an inhibitor ofScience translational medicine · 2017Article
- Hidden reservoir of resistant parasites: the missing link in the elimination of falciparum malaria.Infectious diseases of poverty · 2017Article
- Gancidin W, a potential low-toxicity antimalarial agent isolated from an endophyticDrug design, development and therapy · 2017Article
- Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway.Parasites & vectors · 2016Article
- Molecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug Production.Frontiers in plant science · 2016Review
Corrections and comments
- Comment on
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
20485420What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.